Drug Trial Radar · NCT01144637
A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Last checked: Nov 19, 2026Latest source record: Jan 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,005
Actual
Start
Feb 2013
Primary completion
Nov 2013
Study completion Jun 2014
Sponsor
- Lead sponsor
- Bavarian NordicIndustry
- Sponsor type
- Industry
- First posted
- Jun 15, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A randomized, double-blind, placebo-controlled Phase III trial to evaluate immunogenicity and safety of three consecutive production lots of IMVAMUNE® (MVA-BN®) smallpox vaccine in healthy, vaccinia-naïve subjects.
Conditions
- Smallpox
Interventions
IMVAMUNE®Biological
0.5 ml IMVAMUNE® vaccine containing at least 1 x 10E8 TCID50 (standard dose)
PlaceboOther
0.5 ml TBS
Primary outcomes
What the sponsor says the trial is designed to measure.
- PRNT GMTTime frame: 2 weeks following the second vaccination
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Alabama Vaccine Research Clinic
Birmingham, Alabama
Anaheim Clinical Trials
Anaheim, California
National Research Institute
Los Angeles, California
Northern California Clinical Research Center (NCCRC)
Redding, California
Therapeutics Clinical Research
San Diego, California
Lynn Institute of the Rockies
Colorado Springs, Colorado
Avail Clinical Research, LLC
DeLand, Florida
Broward Research Group
Hollywood, Florida
Accelovance Melbourne
Melbourne, Florida
Southeast Regional Research Group
Savannah, Georgia
Advanced Clinical Research, Inc.
Meridian, Idaho
Accelovance Peoria
Peoria, Illinois
Heartland Research Associates
Augusta, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Benchmark Research
Metairie, Louisiana
QPS Bio-Kinetic
Springfield, Missouri
Washington University in St. Louis, School of Medicine
St Louis, Missouri
Meridian Clinical Research, LLC
Omaha, Nebraska
Clinical Research Center of Nevada, LLC
Las Vegas, Nevada
Rochester Clinical Research, Inc.
Rochester, New York
Wake Research Associates
Raleigh, North Carolina
Rapid Medical Research, Inc.
Cleveland, Ohio
Family Practice Center of Wooster
Wooster, Ohio
Lynn Health Science Institute
Oklahoma City, Oklahoma
Columbia Research Group, Inc.
Portland, Oregon
Omega Medical Research
Warwick, Rhode Island
PMG Research of Charleston
Mt. Pleasant, South Carolina
Holston Medical Group
Bristol, Tennessee
Volunteer Research Group
Knoxville, Tennessee
Benchmark Research
Fort Worth, Texas
Tanner Clinic
Layton, Utah
Advanced Clinical Research
West Jordan, Utah
Clinical Research Associates of Tidewater
Norfolk, Virginia
University Physicians Internal Medicine University Physicians & Surgeons, Inc.
Huntington, West Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.